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Abstract
Background: Asymptomatic bacteriuria in the elderly commonly results in antibiotic administration and, in turn,
contributes to antimicrobial resistance, adverse drug events, and increased costs. This is a major problem in the
long-term care facility (LTCF) setting, where residents frequently transition to and from the acute-care setting,
often transporting drug-resistant organisms across the continuum of care. The goal of this study was to assess
the feasibility and efficacy of antimicrobial stewardship programs (ASPs) targeting urinary tract infections (UTIs)
at community LTCFs.
Methods: This was a quasi-experimental study targeting antibiotic prescriptions for UTI using time-series analysis
with 6-month retrospective pre-intervention and 6-month intervention period at three community LTCFs. The
ASP team (infectious diseases (ID) pharmacist and ID physician) performed weekly prospective audit and feedback
of consecutive prescriptions for UTI. Loeb clinical consensus criteria were used to assess appropriateness of
antibiotics; recommendations were communicated to the primary treating provider by the ID pharmacist.
Resident outcomes were recorded at subsequent visits. Generalized estimating equations using segmented
regression were used to evaluate the impact of the ASP intervention on rates of antibiotic prescribing and
antibiotic resistance.
Results: One-hundred and four antibiotic prescriptions for UTI were evaluated during the intervention, and
recommendations were made for change in therapy in 40 (38 %), out of which 10 (25 %) were implemented.
Only eight (8 %) residents started on antibiotics for UTI met clinical criteria for antibiotic initiation. An immediate
26 % decrease in antibiotic prescriptions for UTI during the ASP was identified with a 6 % reduction continuing
through the intervention period (95 % Confidence Interval ([CI)] for the difference: −8 to −3 %). Similarly, a 25 %
immediate decrease in all antibiotic prescriptions was noted after introduction of the ASP with a 5 % reduction
continuing throughout the intervention period (95 % CI: −8 to −2 %). No significant effect was noted on resistant
organisms or Clostridium difficile.
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Conclusion: Weekly prospective audit and feedback ASP in three community LTCFs over 6 months resulted in
antibiotic utilization decreases but many lost opportunities for intervention.
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Background
Asymptomatic bacteriuria in the elderly commonly results
in antibiotic administration despite evidence showing no
clinical benefit [1–6]. In turn, antibiotic overuse contrib-
utes to antimicrobial resistance, adverse drug events, and
increased costs in the long-term care facility (LTCF) popu-
lation [7–17]. As the elderly population grows, these con-
sequences become more problematic.
Currently, over 3 million individuals reside in LTCFs
in the United States, and the complexity of underlying
conditions is increasing [18]. Correspondingly, these resi-
dents frequently transition to and from the acute-care set-
ting, often transporting drug-resistant organisms across
the continuum of care [19, 20]. Recently published work
assessing prevalence of drug-resistant organisms in LTCFs
indicates that antimicrobial stewardship efforts are neces-
sary [21, 22].
Antimicrobial stewardship programs (ASP) are viewed
as resident safety initiatives designed to improve clinical
outcomes while reducing adverse effects [23]. These types
of programs have proven to be effective in acute care
hospitals and LTCFs affiliated with tertiary care cen-
ters but have not been as well-studied in community
LTCFs [24–34]. Because staffing levels, patient care
models, and overall goals differ between the LTCF
and the acute care settings, the ideal design and exe-
cution of an ASP in the LTCF setting will likely diverge. In
addition, since September 2009 when the Interpretative
Guidelines for Long-Term Care Facilities was issued, the
Centers for Medicare and Medicaid Services (CMS) have
stated that it is the LTCF physician’s responsibility to pre-
scribe appropriate antibiotics and to establish the indica-
tion for use of these medications; furthermore, consultant
pharmacists are encouraged to review indications for anti-
biotic use and report findings to the physician [35]. Des-
pite this regulatory backbone, it remains unclear how best
to implement ASPs in the LTCF setting.
The objectives of this study were to assess the feasibility
and efficacy of implementing an ASP utilizing a syndromic




A prospective quasi-experimental study was performed to
implement an ASP targeted at UTIs diagnosed and treated
at three community LTCFs in Northern California between
September 2011 and May 2012. The ASP team con-
sisted of an Infectious Diseases (ID)-trained clinical
pharmacist and an ID physician, who worked closely
with the infection control practitioners at each of the
respective LTCFs.
The study period was divided into two phases: pre-
intervention (7 months) and intervention (7 months).
During the pre-intervention phase, baseline informa-
tion on facility-level antimicrobial susceptibility pat-
terns and antimicrobial utilization were collected from
each LTCF. During the intervention phase, the ID
pharmacist made weekly site visits to each LTCF to
identify residents receiving antibiotics for UTIs which
was determined by infection control and nursing ad-
ministration records at each site. Individual variables,
including resident demographics, comorbidities, vital
signs, documented exam findings, laboratory results,
and additional antibiotics for each resident on antibi-
otics for UTI, were collected weekly by the ID pharma-
cist by review of the medical record. The ID pharmacist
and ID physician then consulted, and recommendations
were formulated utilizing the Loeb clinical consensus
criteria for initiation of antibiotics in the LTCF setting
as a guideline [36]. For residents not meeting clinical
consensus criteria, the ASP team used clinical judge-
ment including input from subspecialists and the resi-
dent’s predisposition for other infections, to determine
if antibiotics were indicated and to help formulate recom-
mendations. The ID pharmacist subsequently conveyed
the ASP recommendations to the primary treating pro-
vider via telephone or fax. Fax was utilized a minority of
the time with one specific provider who expressed a pref-
erence for this form of communication. Implementation
of recommendations and clinical course of each resident
was recorded at subsequent visits, including vital sign
abnormalities, white blood cell count, change in antibi-
otics, need to transfer to acute care, or death. Data on
facility-level antibiotic susceptibility patterns and anti-
biotic utilization was collected, in a similar manner to the
pre-intervention phase, for the intervention phase.
Ethics, consent, and permissions
This study was reviewed by the Committee for the
Protection of Human Subjects of the California Health
and Human Services Agency and was deemed not to be
research and therefore exempt from approval. As a result
and because implementation of this study was evaluated
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as a quality improvement initiative, consent was not ob-
tained from residents in the participating facilities.
Setting and population
This intervention took place at three community, stand-
alone LTCFs in Northern California: facility A is licensed
for 77 subacute beds and 82 skilled nursing beds with 3
physicians; facility B has 478 licensed skilled nursing
beds with 5 physicians and 1 nurse practitioner; facility
C is comprised of two sister facilities located blocks
away from each other and licensed for 60 and 65 skilled
nursing beds respectively with 2 physicians and 1 nurse
practitioner. Because the medical staff and population of
these latter two facilities overlap significantly, facility C
was analyzed as one LTCF. Subjects included any resi-
dent of the skilled nursing or subacute sections of these
LTCFs being treated for UTI with an antibiotic at the
time of the ID pharmacist visit each week. Subjects were
excluded if they resided in the psychiatric or acute re-
habilitation units at each facility or if antibiotic initiation
for UTI occurred at an acute care facility.
Process and outcome measurements
Outcome of recommendations and clinical course for
residents experiencing ASP interventions were recorded
at subsequent visits through chart review. Recommen-
dations were considered “accepted” if the suggested
change (or discontinuation) of antimicrobials was made
within 24 h of the ASP recommendation being commu-
nicated. Resident-days were collected from each facility.
Antibiotic use was measured as antibiotic starts per
1000 resident-days. Data on antibiotic starts were ob-
tained from the infection control practitioner at each
facility. All LTCFs utilized a maintenance log of all anti-
biotic starts, which included indication for the anti-
biotic, allowing for determination of both a UTI and
overall rate of antibiotic use.
Culture data, including information on susceptibility, was
obtained from the diagnostic laboratories utilized by each
of the facilities. As a marker for potential downstream con-
sequence of antibiotic pressure, we collected information
on rates of Clostridium difficile, ceftriaxone-resistant En-
terobacteriaceae (including extended-spectrum β-lactamase
(ESBL) producing organisms), fluoroquinolone-resistant
Pseudomonas aeruginosa, and vancomycin-resistant En-
terococci isolated from any site for each facility. Rates of
these organisms were calculated from cultures that were
collected as a part of routine clinical care. An individual
resident could contribute more than one clinical culture
since the unit of measurement was the culture. Rates were
calculated based on number of cases of each resistant or-
ganism normalized to resident-days.
Analysis
Generalized estimating equations using segmented re-
gression and a Poisson distribution accounting for clus-
tering by facility were used to evaluate the impact of the
ASP intervention on rates of antibiotic prescribing and
antibiotic resistance. This model generated four import-
ant estimates: 1. The pre-intervention trend in incidence
(β1); 2. The immediate change upon initiation of the
ASP (β2); 3. The difference between the pre- and inter-
vention trend (β3); and 4. The intervention period rate
change (β1+ β3) [37]. The combination of β1 and β3
prevented the attribution of changes preceding the inter-
vention from being attributed to the effects of the inter-
vention. Because of the concern for autocorrelation
between observations over the time of this study given
the time-series design, first order positive and negative
autocorrelation was assessed using the Durbin-Watson
statistic, which did not suggest evidence of autocorrel-
ation in these models. Robust standard errors were
used to estimate variance. Significance was defined as
P ≤ 0.05. STATA software (ver 11, StataCorp 2009) was
used for all statistical analyses except the Durbin-
Watson statistic, which were performed with SAS
version 9.3 (SAS Institute Inc., Cary, NC).
Results
Resident characteristics
During the historical pre-intervention phase (April
2011–October 2012), there were combined 118,070
resident-days from the participating LTCFs. During the
intervention phase (November 2012–May 2012), there
were combined 113,220 resident-days from the LTCFs.
Table 1 demonstrates the baseline characteristics of the
104 reviewed prescriptions during the intervention.
The average temperature and white blood cell counts
for residents were within the normal range. Most resi-
dents had pyuria and positive markers of urinary tract
inflammation on urinalysis. Despite these findings, only
8 % of residents started on antibiotics for UTI who
were evaluated during the intervention met the Loeb
minimum criteria for antibiotic initiation [36]. Of those
meeting Loeb criteria, 6 % were not catheterized and
2 % catheterized. Both of the catheterized residents met
Loeb criteria on fever alone. In those non-catheterized
residents meeting criteria, 33 % had dysuria plus urin-
ary frequency, 33 % had dysuria plus incontinence,
17 % had fever plus hematuria, and 17 % had fever plus
incontinence.
Escherichia coli was the most common urinary organ-
ism treated (in 70 % of residents), and gram-negative rods
predominated the positive urine cultures (accounting for
95 % of treated urine cultures). Of the prescriptions that
were reviewed, fluoroquinolones were the most commonly
prescribed antibiotics (9 prescriptions, 39 %), followed by
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nitrofurantoin (5 prescriptions, 22 %), trimethoprim-
sulfamethoxazole (4 prescriptions, 17 %), cephalexin (3
prescriptions, 13 %), and amoxicillin +/− clavulanate (2
prescriptions, 9 %). Intravenous therapy was infrequently
prescribed.
Process measures
There were 292 prescriptions for UTI during the pre-
intervention phase and 183 during the intervention. Of
the 183 prescriptions for UTI, 104 were able to be
reviewed by the Pharmacist. Of these, recommendations
for change in therapy were made in 38 %, and 10 (25 %)
were accepted. Twenty-four percent of the recommen-
dations were to discontinue antibiotics; 2 % to stream-
line antibiotics; and 11 % to shorten the course of
antibiotics. No recommendations were made to broaden
antibiotics, lengthen course, or change route. The major-
ity of recommendations were made by phone. A small
minority (<5 %) were made by fax.
Of the 59 % of antibiotic prescriptions for UTI where
recommendations were not communicated to the pri-
mary provider, there was either agreement with current
management (12 residents, 19 %) or completion of the
antibiotic course within 2 days from the time of review
(52 residents, 81 %). Because the antimicrobial course
was due to end concurrently with review, interventions
were not made in the latter group. Of this group of 52
residents, antibiotics were not felt to be indicated in 44
(85 %). Of note, the percentage of residents where there
was concordance with antibiotic management exceeded
the percentage meeting Loeb criteria for UTI. In the cases
where there was a discrepancy, the ASP team considered
extenuating circumstances, including recommendations
for antibiotics from other subspecialists, family dynamics,
and concurrent treatment for other infections. The re-
mainder of antibiotic prescriptions was not reviewed due
to an inability to determine if the prescription was for
UTI, the entire antibiotic course was completed in be-
tween weekly ID Pharmacist visits, or the antibiotic was
initiated in an acute care setting.
Outcome measures
Crude incidence rates for antibiotic prescriptions and re-
sistant organisms are shown in Table 2. Incidence rate ra-
tios for the segmented regression for antibiotic utilization
are shown in Table 3. Monthly rates, both measured and
predicted by our statistical model, for antibiotic starts are
shown in Fig. 1. During the pre-intervention phase, there
was a trend towards a significant increase in antibiotic
starts for UTI (4 % increase, P = 0.06). Upon initiation of
the ASP intervention, a 26 % immediate decrease in anti-
biotic prescriptions for UTI was observed, and there was a
9 % change in the trend from the pre-intervention phase
to the intervention phase. After the initial intervention ef-
fect, there was a 6 % decrease in the rate of antibiotic pre-
scriptions for UTI per month continuing throughout
the intervention period (95 % Confidence Interval
[CI]: −8 to −3 %). There was no change in antibiotic
prescription rates for all indications during the pre-
intervention phase. With the introduction of the inter-
vention, there was a 25 % decrease in all antibiotic
Table 2 Crude incidence rates for antibiotic starts
















UTI urinary tract infection
aN/1000 resident-days for antibiotic measurements
Table 1 Characteristics of residents started on antibiotics for
urinary tract infection who were reviewed during the intervention
Baseline characteristic Intervention
(n = 104)
Age, mean, years (Standard Deviation (SD)) 80.8 (14.4)
Male gender, number (%) 70 (67)




Charlson comorbidity index, median (IQR) 2 (1–3)
Temperature, mean, F (SD) 98.2 (1.1)
Indwelling catheter in prior 48 h, number (%) 7 (7)
WBC × 109/L, mean (range) 9.9 (4.1–21.3)
Urine WBCs/hpf >10, n (%) 89 (86)
Urine leukocyte esterase, number/total sent (%) 89/91 (98)
Urine nitrites, number/total sent (%) 51/91 (56)
Meets criteria for UTI, n (%) 8 (8)
No catheter 6 (75)
Catheter 2 (25)
IQR interquartile range, WBC white blood cell count, hpf high-powered field,
SD standard deviation, UTI urinary tract infection
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Table 3 Incidence rate-ratios for an interrupted time-series model of antibiotic prescriptions
Parameter Co-efficient Incidence rate ratio (95 % confidence interval) P-value
Antibiotic starts, UTI
Pre-intervention trend β1 1.04 (1.00–1.07) 0.06
Immediate intervention change β2 0.74 (0.64–0.84) <0.001
Change in trend after intervention β3 0.91 (0.89–0.93) <0.001
Intervention trend β1 + β3 0.94 (0.92–0.97) <0.001
All antibiotic starts
Pre-intervention trend β1 1.04 (0.96–1.13) 0.30
Immediate intervention change β2 0.75 (0.67–0.84) <0.001
Change in trend after intervention β3 0.91 (0.81–1.02) 0.09
Intervention trend β1 + β3 0.95 (0.92–0.98) 0.001
Fig. 1 a Predicted and actual rates for antibiotic starts for UTI per 1000 resident-days; (b) Predicted and actual rates for antibiotic starts for all
indications per 1000 resident-days. Predicted rates are based on the intervention trend calculated from the time-series model. The intervention
started in month 8
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prescriptions. After this initial decrease, there was a
non-significant trend toward decreasing antibiotic pre-
scriptions compared to the pre-intervention phase
(95 % CI: −19 to 2 %). During the entire intervention
phase, there was a 5 % decrease in all antibiotic starts.
To evaluate the consequence of antibiotic pressure on
clinical cultures for common resistant organisms, rates of
Clostridium difficile, ceftriaxone-resistant Enterobacteria-
caeae, fluoroquinolone-resistant Pseudomonas aeruoginosa,
and vancomycin-resistant Enterococci were examined.
There were no significant changes in rates of any of these
organisms throughout the study period (data not shown).
Discussion
Introduction of a weekly prospective audit and feedback
ASP in three community LTCFs resulted in modest de-
creases in antibiotic utilization but encountered several
barriers to effective ASP implementation. Despite having
a dedicated ID pharmacist and physician available once
weekly for reviews, there were many missed opportun-
ities for intervention and low acceptance rates when
recommendations were made.
Given the modest effect observed with implementation
of our ASP in this study, we have identified several areas
for improvement in future interventions. First, given that
85 % of the prescriptions that were not reviewed were
deemed unnecessary, an ASP with more frequent review
of residents on antibiotics might be more useful, though
it may not be feasible with resource limitations and the
general unavailability of ID physicians and pharmacists
in the LTCF setting. More education and training of
non-Infectious Diseases specialized providers may help
to bolster a more robust ASP at these facilities.
Second, there were many missed opportunities for
intervention to improve or to identify prescribing habits
associated with good antimicrobial stewardship, even if
the recommendation would not affect that particular
course of antimicrobials (e.g. in the case of a resident
whose course was scheduled to end the day of review).
In future studies, educational feedback with the goal of
broadly changing antimicrobial prescribing habits may
be more successful. The large initial decrease in anti-
microbial prescriptions suggests that knowledge of pro-
gram implementation itself may have affected prescribing
practice; whether this decrease would have been sustained
longer than 6 months warrants further investigation.
In addition, our largest barrier was establishing rela-
tionships with prescribers in this setting as compared
with acute care. Because much of the medical care oc-
curs remotely in the LTCF population, establishing inter-
personal relationships between the ASP and the primary
treating providers proved challenging due to lack of
face-to-face interaction and lack of a prior provider-to-
provider relationship. This barrier limited physician and
advanced care practitioner buy-in and implementation
of recommendations. In future interventions, it may be
helpful if the ASP champion was identified from within
the institution, though this may be problematic if suffi-
cient knowledge of antimicrobial stewardship principles
is lacking at the local level. If stewardship is to be initi-
ated by an outside consultant, concerted efforts to estab-
lish a relationship with providers should be pursued,
such as educational seminars, face-to-face meetings, and
collaboration in design of the program.
Lastly, primary treating providers reported feeling
pressured by nursing staff and, to some extent, resident
families to send urinalyses and urine cultures for indica-
tions such as cloudy urine, foul-smelling urine, or tem-
porary behavior changes. When these cultures tested
positive, regardless of whether the symptoms had disap-
peared prior to therapy, the residents were often treated.
Front-line staff education must remain a specific focus
of future ASP interventions in the LTCF setting since
this group plays a vital role in establishing the prescrib-
ing culture of an institution. A recent study at the VA
Healthcare System, which included an associated long-
term care facility, found that an educational campaign
aimed to improve treatment for catheter-associated UTI
decreased the number of urine cultures sent by 71 %,
which corresponded to a 76 % decrease in overtreatment
for asymptomatic bacteruria [38]. The decreases were
most pronounced in the LTCF portion of the study.
Stewardship of urinalysis and urine culture, including
among nursing staff and families, may be an effective
upstream method for decreasing inappropriate antibiotic
use for UTI in the LTCF setting. In fact, in the acute
care setting, a recent pilot study demonstrated that sup-
pressing urine culture results in noncatheterized patients
resulted in decreased treatment of asymptomatic bacteri-
uria without any untoward consequences [39]. Though
this degree of intervention may be risky and require more
resources, it does support the notion that limiting cultures
may limit overtreatment of asymptomatic bacteriuria.
Our study has several additional important limitations
aside from the barriers to success. Because it took place
over a 14-month period, the pre-intervention and inter-
vention phases occurred during different seasons, so
temporal trends could not be eliminated. We attempted
to adjust for this with our statistical analyses by using a
time-series analysis approach. In addition, the 2011–2012
influenza season was accounted for mainly during the
intervention phase, so antibiotic prescriptions would be
expected to increase during the intervention, which is the
opposite of what was observed. We only identified 104
cases of treated UTI in three nursing homes in 6 months
of our study intervention so our study power was lower
than expected but sometimes unavoidable in real-life re-
search. In order to identify cases we relied on Infection
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Control reports of antimicrobial prescriptions, which may
have been limited by recall bias. Obtaining prescription
data would have allowed for a more objective measurement
of prescriptions during the pre- and post-intervention
periods. It would also have allowed for more information
regarding days of therapy and length of therapy. Unfortu-
nately, we did not have access to pharmacy records at two
of the sites due to pharmacies being located off-site and
operated by third-party vendors.
Several other groups have implemented stewardship
initiatives in the LTCF setting with varied success. Jump
and colleagues found an even larger decrease in anti-
microbial utilization with initiation of an ID service at a
LTCF associated with a Veterans Affairs Hospital [40].
That study included a more resource-intensive and com-
prehensive approach to antimicrobial stewardship with a
team that physically staffed consults during weekly visits
and took additional calls throughout the week, a model
that is unlikely to be feasible, especially at LTCFs that are
not academically affiliated. Several other studies have
explored less resource-intensive approaches, such as edu-
cational interventions. Two studies have demonstrated
approximately 30 % decrease in antimicrobial prescribing
for UTI after educational interventions aimed at appropri-
ate evaluation and treatment of UTI versus asymptomatic
bacteriuria [29, 33]. Additional studies have demonstrated
12–30 % decreases in antibiotic use with educational in-
terventions focused on appropriate diagnosis and treat-
ment of common infectious syndromes [31, 32]. The
decrease in antibiotic use in our study was lower than that
seen with the educational interventions alone. However,
the most effective published strategy is an educational
intervention consisting of mailing an antibiotic prescribing
guide combined with physician-specific antibiotic pre-
scribing profiles (physicians in the experimental group
were 64 % less likely to prescribe non-adherent antibiotics
than those in the control group (Odds Ratio = 0.36, 95 %
CI = 0.18–0.73), suggesting that physician feedback is an
essential component [30]. Provider characteristics have
been demonstrated to play an important role in dur-
ation of antibiotic prescriptions independent of severity
of underlying disease, suggesting that high-prescribing
physicians may be good targets for these types of ASP
interventions [41]. Combining education with an audit
and feedback ASP would allow for targeted physician
feedback and therefore even more benefit on improving
prescribing habits.
Conclusion
Our findings suggest that an ASP with a syndromic ap-
proach has the potential to be effective in the LTCF set-
ting but further studies are needed to determine the
most robust and efficient design for such an intervention.
The addition of an educational program with prescriber
feedback, which has proven beneficial in prior studies,
might strengthen the benefits of an audit and feedback
ASP alone. Our ASP was not able to provide as much
educational support given that the ASP team and primary
treating providers were not often at the LTCF at the same
time. A dedicated educational aspect to the ASP would
also allow for institutional changes such as educating the
nursing staff in identifying residents at risk and diagnosing
bacteriuria as well as the conviction from providers that
positive cultures mandate therapy. Moving forward, quali-
tative analyses may be important to identify key stake-
holders in the antibiotic prescribing process in LTCFs.
Design of future interventions should incorporate educa-
tion targeting these stakeholders as well as focused audit
and feedback of prescriptions for specific common infec-
tious syndromes.
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